Author/Authors
namdaroğlu, sinem izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, Turkey , medeni, şerife solmaz izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, turkey , çetintepe, tuğba izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, Turkey , namdaroğlu, ozan barış izmir bozyaka eğitim ve araştırma hastanesi - genel cerrahi kliniği, İzmir, Turkey , bilgir, oktay izmir bozyaka eğitim ve araştırma hastanesi - hematoloji kliniği, İzmir, Turkey
Title Of Article
Refrakter trombositopeni ile seyreden Faktör V Leiden mutasyonu olan primer antifosfolipid sendromlu olguda eltrombopag deneyimi
شماره ركورد
22721
Abstract
Antiphospholipid antibody syndrome (APS) is a systemic autoimmune disorder characterized by recurrent arterial or venous thrombosis, fetal loss, thrombocytopenia, neurological symptoms and presence of serum antiphospholipid antibodies (AFA). In this report,we present a young male patient with thrombocytopenia who was refractory to steroids, intravenous immunoglobulin and splenectomy but had complete response to eltrombopag treatment, FV Leiden heterozygous mutant positive, also had a history of sinüs thrombosis taking oral anticoagulant treatment has been diagnosed primary APS. Eltrombopag treatment primary antiphospholipid syndrome patient associated with refractory thrombocytopenia.
From Page
67
NaturalLanguageKeyword
Eltrombopag , Primary antiphospholipid syndrome , Thrombocytopenia , Factor V Leiden
JournalTitle
Pamukkale Medical Journal
To Page
72
JournalTitle
Pamukkale Medical Journal
Link To Document